Cite
HARVARD Citation
Gatto, M. et al. (2021). Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort. Journal of autoimmunity. p. . [Online].